Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Medical Marijuana, Inc. (MJNA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0112-0.0001 (-0.88%)
At close: 03:56PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0113
Open0.0113
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0100 - 0.0115
52 Week Range0.0100 - 0.0400
Volume2,255,950
Avg. Volume4,451,377
Market Cap56.488M
Beta (5Y Monthly)0.82
PE Ratio (TTM)5.60
EPS (TTM)0.0020
Earnings DateNov 15, 2022 - Nov 21, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MJNA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MEDICAL MARIJUANA INC
    Analyst Report: Deere & CompanyDeere is the world’s leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • GlobeNewswire

    Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region

    Global Cannabis Company Expands Supply Chain in Europe through Agreement with Complete Hemp Technologies SAN DIEGO, CA, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary, Kannaway, has signed a distribution agreement with long-time pa

  • GlobeNewswire

    Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results

    SAN DIEGO, CA, Aug. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced its financial results for the quarter ending June 30, 2022, and provided an overview of recent operational highlights. Second Quarter 2022 Financial and Operational Highlights ● Generated $7.8 mi

  • GlobeNewswire

    Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil

    SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its pharmaceutical subsidiary, HM Pharma, has submitted a product dossier for its cannabidiol (CBD) products after receiving Sanitary Authorization from ANVISA, Brazil’s Health Regulatory Ag

Advertisement
Advertisement